To determine whether the EBV neutralizing antibodies induced by EBV core fusion machinery envelope proteins gH/gL and trimeric gB are protective against EBV infection in vivo, we performed passive immune protection studies using humanized mice. The gene discussed is ERVW-1; the disease is Epstein-Barr virus infection.